Published in Biomaterials on December 01, 2000
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel) (2011) 3.62
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35
The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta (2011) 1.64
Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater (2009) 1.60
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnology (2011) 1.39
Silver/poly (lactic acid) nanocomposites: preparation, characterization, and antibacterial activity. Int J Nanomedicine (2010) 1.31
Intravenous hemostat: nanotechnology to halt bleeding. Sci Transl Med (2009) 1.29
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine (2011) 1.26
A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices. Biomaterials (2008) 1.24
Electrohydrodynamics: A facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev (2009) 1.23
Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin. J Control Release (2011) 1.20
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int J Nanomedicine (2008) 1.20
Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev (2012) 1.14
Monofunctional and higher-valent platinum anticancer agents. Inorg Chem (2013) 1.13
Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl (2011) 1.13
Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine (2013) 1.12
A drug-eluting contact lens. Invest Ophthalmol Vis Sci (2009) 1.08
PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp (2013) 1.04
Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics (2009) 1.03
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev (2016) 1.02
Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects. Biomaterials (2010) 1.00
Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc Natl Acad Sci U S A (2010) 1.00
Nanobead-based interventions for the treatment and prevention of tuberculosis. Nat Rev Microbiol (2010) 0.99
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol (2011) 0.98
Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles. PLoS One (2013) 0.98
Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord. Acta Biomater (2009) 0.97
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int J Pharm (2010) 0.97
The use of BMP-2 coupled - Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials (2010) 0.96
Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol (2010) 0.95
One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles. J R Soc Interface (2009) 0.94
Electrostatic surface modifications to improve gene delivery. Expert Opin Drug Deliv (2010) 0.94
Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility. Acta Biomater (2009) 0.93
Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts. Pharm Res (2009) 0.93
Biodegradable poly(lactide-co-glycolide) coatings on magnesium alloys for orthopedic applications. J Mater Sci Mater Med (2012) 0.93
Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proc Natl Acad Sci U S A (2008) 0.93
Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. J Control Release (2013) 0.93
Encapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film. AAPS PharmSciTech (2005) 0.92
Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo. J Mater Sci Mater Med (2006) 0.91
Bioeliminable nanohydrogels for drug delivery. Nano Lett (2008) 0.91
Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm Res (2008) 0.91
Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films. J Ocul Pharmacol Ther (2013) 0.90
Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres. Mater Sci Eng C Mater Biol Appl (2013) 0.90
Coaxial electrospray of microparticles and nanoparticles for biomedical applications. Expert Rev Med Devices (2012) 0.90
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Int J Nanomedicine (2012) 0.90
Silicon micro- and nanofabrication for medicine. Adv Healthc Mater (2013) 0.90
Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights. Crit Rev Ther Drug Carrier Syst (2013) 0.90
Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors. J Control Release (2014) 0.90
Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng Part A (2011) 0.89
Surface-mediated release of a synthetic small-molecule modulator of bacterial quorum sensing: gradual release enhances activity. Chem Commun (Camb) (2010) 0.89
Microencapsulation: A promising technique for controlled drug delivery. Res Pharm Sci (2010) 0.88
Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Int J Nanomedicine (2013) 0.88
Inhibition of angiogenesis- and inflammation-inducing factors in human colon cancer cells in vitro and in ovo by free and nanoparticle-encapsulated redox dye, DCPIP. J Nanobiotechnology (2010) 0.88
Preparation of porous biodegradable poly(lactide-co-glycolide)/ hyaluronic acid blend scaffolds: characterization, in vitro cells culture and degradation behaviors. J Mater Sci Mater Med (2006) 0.87
Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel. Int J Mol Sci (2011) 0.87
Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity. Front Oncol (2012) 0.87
India ink incorporated multifunctional phase-transition nanodroplets for photoacoustic/ultrasound dual-modality imaging and photoacoustic effect based tumor therapy. Theranostics (2014) 0.87
Development and validation of a high-performance liquid chromatography method for the simultaneous determination of aspirin and folic acid from nano-particulate systems. Biomed Chromatogr (2010) 0.87
Noninvasive assessment of localized inflammatory responses. Free Radic Biol Med (2011) 0.87
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials (2013) 0.87
Nanoparticles containing insoluble drug for cancer therapy. Biotechnol Adv (2013) 0.86
ToF-SIMS analysis of chemical heterogenities in inkjet micro-array printed drug/polymer formulations. J Mater Sci Mater Med (2011) 0.86
Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability. AAPS PharmSciTech (2014) 0.85
Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice. PLoS One (2012) 0.85
A novel artificial nerve graft for repairing long-distance sciatic nerve defects: a self-assembling peptide nanofiber scaffold-containing poly(lactic-co-glycolic acid) conduit. Neural Regen Res (2014) 0.84
Physicochemical properties and applications of poly(lactic-co-glycolic acid) for use in bone regeneration. Tissue Eng Part B Rev (2013) 0.84
Development of a pH-responsive particulate drug delivery vehicle for localized biologic therapy in inflammatory bowel disease. Yale J Biol Med (2011) 0.84
Biodegradable-Polymer-Blend-Based Surgical Sealant with Body-Temperature-Mediated Adhesion. Adv Mater (2015) 0.83
Fluorescence imaging enabled poly(lactide-co-glycolide). Acta Biomater (2015) 0.83
Silica-based mesoporous nanoparticles for controlled drug delivery. J Tissue Eng (2013) 0.83
Use of a nanoporous biodegradable miniature device to regulate cytokine release for cancer treatment. J Control Release (2011) 0.83
Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR. Mol Pharm (2010) 0.83
Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin. Int J Nanomedicine (2012) 0.83
5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy. J Mater Sci Mater Med (2012) 0.83
Glycolic acid-catalyzed deamidation of asparagine residues in degrading PLGA matrices: a computational study. Int J Mol Sci (2015) 0.82
A Fractional Factorial Design to Study the Effect of Process Variables on the Preparation of Hyaluronidase Loaded PLGA Nanoparticles. Enzyme Res (2014) 0.82
Multilayer films assembled from naturally-derived materials for controlled protein release. Biomacromolecules (2014) 0.82
Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells. J Pharm Sci (2010) 0.82
Nanoformulated cell-penetrating survivin mutant and its dual actions. Int J Nanomedicine (2014) 0.82
Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage. Int J Nanomedicine (2013) 0.82
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity. Hum Vaccin Immunother (2016) 0.82
Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. Int J Pharm (2013) 0.81
Nanoprecipitation is more efficient than emulsion solvent evaporation method to encapsulate cucurbitacin I in PLGA nanoparticles. Saudi Pharm J (2013) 0.81
Experimental design and instability analysis of coaxial electrospray process for microencapsulation of drugs and imaging agents. J Biomed Opt (2013) 0.81
Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application. Pharm Res (2013) 0.81
Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases. J R Soc Interface (2013) 0.81
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis. PLoS One (2013) 0.81
A prototype antifungal contact lens. Invest Ophthalmol Vis Sci (2011) 0.81
Adenovirus-mediated transfer of VEGF into marrow stromal cells combined with PLGA/TCP scaffold increases vascularization and promotes bone repair in vivo. Arch Med Sci (2012) 0.81
Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury. J Control Release (2015) 0.81
Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model. Biomaterials (2015) 0.81
The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomedicine (2012) 0.81
Ease of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles. ChemMedChem (2010) 0.81
Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles. Biomaterials (2013) 0.80
(-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease. Parasitol Res (2010) 0.80
Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. Mol Pharm (2013) 0.80
Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form. Evid Based Complement Alternat Med (2010) 0.80
Effect of silk protein processing on drug delivery from silk films. Macromol Biosci (2013) 0.80
Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways. Adv Healthc Mater (2013) 0.80
Nanoparticles of polyethylene sebacate: a new biodegradable polymer. AAPS PharmSciTech (2009) 0.79